Journal
ISCIENCE
Volume 25, Issue 11, Pages -Publisher
CELL PRESS
DOI: 10.1016/j.isci.2022.105390
Keywords
-
Categories
Funding
- National Institutes of Health [R01HL137771, R21AG058983, R21AA026922, 1UL1TR001430]
- Evans Medical Foundation
- Boston University Undergraduate Research Opportunity Program
Ask authors/readers for more resources
Aortic endothelial cell dysfunction is a trigger of atherosclerosis. This study investigates the efficacy of nanocapsules in delivering fluorescent dye to the vascular system, showing its potential as a therapeutic solution for cardiovascular disease.
Aortic endothelial cell dysfunction is an early trigger of atherosclerosis, the major cause of the cardiovascular disease (CVD). Nanomedicines targeting vascular endothelium and lesions hold great promise as therapeutic solutions to vascular disorders. This study investigates the vascular delivery efficacy of polyurethane-polyurea nanocapsules (Puua-NCs) with pH-synchronized shell cationization and redox-triggered release. Fluorescent liporhilic dye Dil was encapsulated into Puua-NCs of variable sizes and concentrations. In vitro cellular uptake studies with human aortic endothelial cells showed that these Puua-NCs were taken up by cells in a dose-dependent manner. In apolipoprotein E-deficient mice fed a Western diet, a model of atherosderosis, circulating Puua-NCs were stable and accumulated in aortic endothelium and lesions within 24 hours after intravenous administration. Treatment with thiol-reducing and oxidizing reagents disrupted the disulfide bonds on the surface of internalized NCs, triggering disassembly and intracellular cargo release. Ultimately, Puua-NCs are a potential redox-controllable cardiovascular drug delivery system.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available